Stay updated on Nivolumab Post-Surgery in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Post-Surgery in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Post-Surgery in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study record area still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T12:24:37.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH updates about using “Super Intelligence” in place of “Artificial Intelligence” during a transition. The study page itself still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-25T12:23:24.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2; the page otherwise remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T13:23:15.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T13:57:52.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The NCT03770299 study page now displays a 403 Forbidden error, replacing the expected study details. The page shows the standard header and footer with an error message, indicating the record is currently inaccessible.
    Difference
    21%
    Check dated 2026-09-20T19:59:52.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The study record now includes an NIH 2018 funding attribution and the revision is updated to v3.6.6, replacing the prior v3.6.5 entry.
    Difference
    0.1%
    Check dated 2026-08-30T22:38:15.000Z thumbnail image

Stay in the know with updates to Nivolumab Post-Surgery in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Post-Surgery in NSCLC Clinical Trial page.